Insights

Conducting Clinical Trials Part 1: When Should You File Your Patent Applications?

Clinical trials have found their way into the spotlight of the coronavirus pandemic as multiple pharmaceutical and biotechnology companies race to develop and market vaccines and therapies. As breakthrough technologies are on the rise, so are the risks associated with vaccine and drug development. “Conducting Clinical Trials” is a podcast miniseries featuring Choate attorneys covering a number of topics related to clinical trials, including common mistakes companies make along the way and various strategic choices they face.

What are some important timing considerations when filing patent applications that cover the results of a clinical trial, particularly in situations where the clinical data are not yet available? As the first installment of Choate’s Conducting Clinical Trials series, Bryana McGillycuddy and John Rearick discuss a range of implications associated with the timing of filing, including the validity of the patent and the risk of inadvertent disclosure.

Listen to additional episodes →

To request a copy of a transcript, please click here.